Risk of differentiation syndrome with enasidenib, warns US FDA

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1732卷 / 1期

关键词：

D O I：

10.1007/s40278-018-55460-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[11] US FDA warns of unauthorised devices for diabetes control
[J]. Reactions Weekly, 2019, 1755 (1) : 8 - 8
[12] US FDA warns of heart issues, death with clarithromycin
[J]. Reactions Weekly, 2018, 1692 (1) : 7 - 7
[13] FDA warns against filling US prescriptions abroad
[J]. Reactions Weekly, 2006, 1086 (1) : 3 - 3
[14] US FDA warns of contamination issues with PNC 27
[J]. Reactions Weekly, 2017, 1636 (1) : 4 - 4
[15] US FDA warns that Ocaliva is being incorrectly dosed
[J]. Reactions Weekly, 2017, 1672 (1) : 9 - 9
[16] US FDA warns of dangers of Miracle Mineral Solution
[J]. Reactions Weekly, 2019, 1767 (1) : 4 - 4
[17] Antidepressants: FDA warns of paediatric suicide risk
[J]. Reactions Weekly, 2003, 976 (1) : 2 - 2
[18] US warns of acetylene risk
Hess, G
[J]. CHEMICAL & ENGINEERING NEWS, 2006, 84 (06) : 8 - 8
[19] FDA WARNS OF RISK FROM HORMONE PRODUCTS
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2018, 253 (08): : 949 - 949
[20] FDA warns of risk of peripheral neuropathy with fluoroquinolones
[J]. Reactions Weekly, 2013, 1466 (1) : 2 - 2

← 1 2 3 4 5 →